TY - JOUR T1 - Effects of voluntary event cancellation and school closure as countermeasures against COVID-19 outbreak in Japan JF - medRxiv DO - 10.1101/2020.03.19.20037945 SP - 2020.03.19.20037945 AU - Yoshiyuki Sugishita AU - Junko Kurita AU - Tamie Sugawara AU - Yasushi Ohkusa Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/28/2020.03.19.20037945.abstract N2 - Background To control the COVID-19 outbreak in Japan, sports and entertainment events were canceled and schools were closed throughout Japan from February 26 through March 19. That policy has been designated as voluntary event cancellation and school closure (VECSC).Object This study assesses VECSC effectiveness based on predicted outcomes. Method: A simple susceptible–infected–recovery model was applied to data of patients with symptoms in Japan during January 14 through March 25. The respective reproduction numbers were estimated before VECSC (R), during VECSC (Re), and after VECSC (Ra).Results Results suggest R before VECSC as 1.987 [1.908, 2.055], Re during VECSC as 1.122 [0.980, 1.260], and Ra after VECSC as 3.086 [2.529, 3.739].Discussion and Conclusion Results demonstrated that VECSC can reduce COVID-19 infectiousness considerably, but the value of R rose to exceed 2.5 after VECSC.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesJapan Ministry of Health, Labour and Welfare. Press Releases. (in Japanese) https://www.mhlw.go.jp/stf/houdou/houdou_list_202001.html. ER -